Read + Share
Hernaez R, Avila MA. Immunogenomic classification of hepatocellular carcinoma patients for immune
check-point inhibitors therapy: cui bono? Gut 2022 Apr 26. pii: gutjnl-2022-327132. doi: 10.1136/gutjnl-2022-327132.
PMID: 35474266
|
 |
|
Hernaez R, Avila MA. Immunogenomic classification of hepatocellular carcinoma patients for immune
check-point inhibitors therapy: cui bono? Gut 2022 Apr 26. pii: gutjnl-2022-327132. doi: 10.1136/gutjnl-2022-327132.
PMID: 35474266
|
|
|
|